| Literature DB >> 35363853 |
Riley D Z Mullins1,2, Ananya Pal1,2, Thomas F Barrett1,2, Molly E Heft Neal2, Sidharth V Puram1,2.
Abstract
Epithelial-mesenchymal transition (EMT) is a fundamental process that occurs during embryogenesis and tissue repair. However, EMT can be hijacked by malignant cells, where it may promote immune evasion and metastasis. Classically considered a dichotomous transition, EMT in cancer has recently been considered a plastic process whereby malignant cells display and interconvert among hybrid epithelial/mesenchymal (E/M) states. Epithelial-mesenchymal plasticity (EMP) and associated hybrid E/M states are divergent from classical EMT, with unique immunomodulatory effects. Here, we review recent insights into the EMP-immune cross-talk, highlighting possible mechanisms of immune evasion conferred by hybrid E/M states and roles of immune cells in EMP. ©2022 American Association for Cancer Research.Entities:
Mesh:
Year: 2022 PMID: 35363853 PMCID: PMC9256788 DOI: 10.1158/0008-5472.CAN-21-4370
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 13.312